Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 294, 27-42
Abstract
No abstract availableKeywords
Funding Information
- Public Welfare Research and Capacity Building Fund of Guangdong (2016A020218006)
- National Natural Science Foundation of China (81473154, 81773659)
- Fundamental Research Funds for the Central Universities (18ykzd08)
This publication has 38 references indexed in Scilit:
- Carrier-free functionalized multidrug nanorods for synergistic cancer therapyBiomaterials, 2013
- The secrets of the Bcl-2 familyCell Death & Differentiation, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to ApplicationsNano Letters, 2010
- Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticlesBiomaterials, 2010
- Targeting mitochondria for cancer therapyNature Reviews Drug Discovery, 2010
- Nanoparticles for Drug Delivery Prepared from Amphiphilic PLGA Zwitterionic Block Copolymers with Sharp Contrast in Polarity between Two BlocksAngewandte Chemie International Edition, 2010
- Targeting mitochondria for cancer therapyEnvironmental and Molecular Mutagenesis, 2010
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990